search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
900


period, there were 935 acute care, nonfederal US hospitals with at least 1 discharge containing a CAUTI HAC code, and 102 of these hospitals had the DRG assignment impacted for at least 1 dis- charge. Table 2 compares the hospital characteristics between the hospitals with DRG changes and those with no DRG changes. For CLABSI, the following characteristics were significantly


more common among hospitals impacted by the CMS HAC policy: hospital in the Northeast region (P=0.05), bed size≥400 (P<.01), and major teaching status (P<.01). For CAUTI, no characteristics were significantly more common among hospitals impacted by the CMS HAC policy, although hospitals in the Northeast region appear to have been impacted the most (P=0.06), similar to CLABSI.


Discussion


One of the main reasons that the 2008 CMS HAC policy may not have accelerated the rate of decline in central line–associated bloodstream infections and catheter-associated urinary tract infections is that the financial penalties were minimal. Billing codes for CLABSI and CAUTI were rarely used, were commonly listed as present on admission in the post-policy period, and infrequently impacted the DRG assignment determining hospital reimbursement. Based on billing for CLABSI and CAUTI not POA in the


postpolicy period, an average of ~6,800 Medicare discharges per year (2009–2011) had a hospital-acquired CLABSI and ~750 Medicare discharges per year (2009–2011) had a hospital- acquired CAUTI. To put this into context, US estimates for annual CLABSI infections range from 60,000 to 92,000, and estimates for annual CAUTI infections range from 63,000 to 450,000.11,12 Even accounting for the fact that Medicare pays for only 39% of US hospitalizations,13 these numbers suggest that claims identified a much lower number of infections than pub- lished surveillance data. This finding is consistent with prior findings in a statewide analysis looking at the use of the CAUTI HAC code.14 Our finding that the majority of HAC codes submitted for


reimbursement shifted to being coded as POA in the postpolicy period deserves further investigation. One study looking at coding practices for CAUTI found that at least one-third of infections listed as POA actuallymet criteria as hospital-acquired infections.15 This result calls into question the accuracy of the POA designation. Delving into this further, our finding that major teaching


hospitals were most impacted by the HAC policy for CLABSI was actually predicted based on an analysis of coding practices in academic medical centers.16 In fact, a prior CAUTI study looking at data through 2009 showed that teaching hospitals were more impacted by the HAC policy than nonteaching hospitals, with private, for-profit hospitals having the greatest decline in coded, non-POA CAUTIs in the year following the policy.17 In the context of a profit incentive, earlier adoption of changes in coding practice may have occurred for certain hospitals. When determining hospital reimbursement based on DRG assignment, other diagnosis codes may be submitted for reim- bursement, limiting the magnitude of change due to ICD-9 codes selected to identify CLABSI and CAUTI.15,18 In addition, the position of a given HAC code in the list of submitted diagnoses may impact the likelihood of change in DRG assignment.19 Thus, recognizing the limitations of HAI performance metrics based on claims for CLABSI and CAUTI, there has been a shift


Michael S. Calderwood et al


toward collecting data using clinical surveillance definitions. The current Hospital-Acquired Condition Reduction Program tracks outcomes for CLABSI and CAUTI based on data self-reported by hospitals to the Centers for Diseases Control and Prevention’s National Healthcare Safety Network (NHSN).20,21 It is hoped that this will lead to better accountability and will increase efforts to reduce preventable healthcare-associated infections. At the same time, concerns have been raised about the impact of financial incentives on the adjudication of which cases are publicly reported. Time will tell if this new HAC Reduction Program has a positive impact on patient outcomes. As for the 2008 CMS HAC policy targeting CLABSI and


CAUTI, the financial disincentives were minimal due to coding practices. Therefore, it is not surprising that there was not a significant impact on reported CLABSI and CAUTI trends based on clinical surveillance definitions. However, our study has a few limitations. First, we only analyzed data through 2011 (3 years postpolicy), although there is no reason to suspect that coding practices have changed. Second, we took the diagnosis codes in Medicare claims to be true, although it is possible that non– device-associated infections could have been erroneously coded as CLABSI or CAUTI (ie, false positives). Third, we only included hospitals subject to IPPS rules, excluding cancer hospitals with a potentially higher risk of both CLABSI and CAUTI. With the evolution of the HAC Reduction Program, hospitals


ranked in the worst quartile based on NHSN reported rates of CLABSI and CAUTI take a percentage reduction on their entire Medicare reimbursement for the year, rather than just on a single encounter. While this has definitely attracted the attention of hospital leadership, it will be important to be vigilant about the impact of these policies on patient outcomes and to monitor for unintended consequences as these payment policies continue to evolve.


Acknowledgments. We are grateful to the members of the Preventing Avoidable Infectious Complications by Adjusting Payment (PAICAP) study team (Ken Kleinman, ScD; Ashish Jha, MD, MPH; and Stephen Soumerai, ScD). We also thank the PAICAP Advisory Board for their guidance and input (Neil Fishman, MD, MA; Scott Fridkin, MD; Don Goldmann, MD; Patricia Grant, RN, BSN, MS; Teresa Horan, MPH; John Jernigan, MD, MS; William Kassler, MD, MPH; and Clifford McDonald, MD).


Financial support. This study was funded by the Agency for Healthcare Research and Quality (grant no. HS018414).


Potential conflicts of interest. All authors report no conflicts of relevant to this article.


References


1. Centers for Medicare and Medicaid Services; Department of Health and Human Services. Medicare program: changes to the hospital inpatient prospective payment systems and fiscal year. 2008 rates. Fed Regist 2007;72:47379–47428.


2. Acute inpatient PPS. Centers for Medicare and Medicaid Services website. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/Acute- inpatientPPS/index.html. Updated 2017. Accessed February 21, 2018.


3. Nguyen OK, Halm EA, Makam AN. Relationship between hospital financial performance and publicly reported outcomes. J Hosp Med 2016;11:481–488.


4. Lee GM, Kleinman K, Soumerai SB, et al. Effect of nonpayment for preventable infections in US hospitals. N Engl J Med 2012;367:1428–1437.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140